Literature DB >> 11739734

ARF function does not require p53 stabilization or Mdm2 relocalization.

Chandrashekhar Korgaonkar1, Lili Zhao, Modestos Modestou, Dawn E Quelle.   

Abstract

It is generally accepted that the ARF tumor suppressor induces p53-dependent growth arrest by sequestering the p53 antagonist Mdm2 in the nucleolus. Previous mutagenic studies of murine ARF suggested that residues 1 through 14 and 26 through 37 were critical for Mdm2 binding, while the latter domain also governed ARF nucleolar localization. We show that mouse ARF residues 6 to 10 and 21 to 25 are required for ARF-induced growth arrest whereas residues 1 to 5 and 29 to 34 are dispensable. Deletion of the putative nucleolar localization signal (31)RRPR(34) did not prevent nucleolar localization. Surprisingly, unlike wild-type ARF, growth-inhibitory mutants D1-5 and D29-34 failed to stabilize p53 yet induced its transcriptional activation in reporter assays. This suggests that p53 stabilization is not essential for ARF-mediated activation of p53. Like wild-type ARF, both mutants also exhibited p53-independent function since they were able to arrest p53/Mdm2-null cells. Notably, other mutants lacking conserved residues 6 to 10 or 21 to 25 were unable to suppress growth in p53-positive cells despite nucleolar localization and the ability to import Mdm2. Those observations stood in apparent contrast to the ability of wild-type ARF to block growth in some cells without relocalizing endogenous Mdm2 to nucleoli. Together, these data show a lack of correlation between ARF activity and Mdm2 relocalization, suggesting that additional events other than Mdm2 import are required for ARF function.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11739734      PMCID: PMC134207          DOI: 10.1128/MCB.22.1.196-206.2002

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  66 in total

Review 1.  Net results of nucleolar dynamics.

Authors:  S N Garcia; L Pillus
Journal:  Cell       Date:  1999-06-25       Impact factor: 41.582

Review 2.  The complexity of p53 modulation: emerging patterns from divergent signals.

Authors:  A J Giaccia; M B Kastan
Journal:  Genes Dev       Date:  1998-10-01       Impact factor: 11.361

Review 3.  Tumor surveillance via the ARF-p53 pathway.

Authors:  C J Sherr
Journal:  Genes Dev       Date:  1998-10-01       Impact factor: 11.361

4.  p19ARF links the tumour suppressor p53 to Ras.

Authors:  I Palmero; C Pantoja; M Serrano
Journal:  Nature       Date:  1998-09-10       Impact factor: 49.962

5.  Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis.

Authors:  C M Eischen; J D Weber; M F Roussel; C J Sherr; J L Cleveland
Journal:  Genes Dev       Date:  1999-10-15       Impact factor: 11.361

6.  Human ARF protein interacts with topoisomerase I and stimulates its activity.

Authors:  L Karayan; J F Riou; P Séité; J Migeon; A Cantereau; C J Larsen
Journal:  Oncogene       Date:  2001-02-15       Impact factor: 9.867

7.  DNA-dependent protein kinase acts upstream of p53 in response to DNA damage.

Authors:  R A Woo; K G McLure; S P Lees-Miller; D E Rancourt; P W Lee
Journal:  Nature       Date:  1998-08-13       Impact factor: 49.962

8.  The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2.

Authors:  F J Stott; S Bates; M C James; B B McConnell; M Starborg; S Brookes; I Palmero; K Ryan; E Hara; K H Vousden; G Peters
Journal:  EMBO J       Date:  1998-09-01       Impact factor: 11.598

9.  Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest.

Authors:  D E Quelle; F Zindy; R A Ashmun; C J Sherr
Journal:  Cell       Date:  1995-12-15       Impact factor: 41.582

Review 10.  The INK4a/ARF tumor suppressor: one gene--two products--two pathways.

Authors:  L Chin; J Pomerantz; R A DePinho
Journal:  Trends Biochem Sci       Date:  1998-08       Impact factor: 13.807

View more
  38 in total

1.  Nucleophosmin is essential for c-Myc nucleolar localization and c-Myc-mediated rDNA transcription.

Authors:  Z Li; S R Hann
Journal:  Oncogene       Date:  2012-06-04       Impact factor: 9.867

2.  Differential regulation of E2F1, DP1, and the E2F1/DP1 complex by ARF.

Authors:  Abhishek Datta; Alo Nag; Pradip Raychaudhuri
Journal:  Mol Cell Biol       Date:  2002-12       Impact factor: 4.272

3.  Alternative reading frame protein (ARF)-independent function of CARF (collaborator of ARF) involves its interactions with p53: evidence for a novel p53-activation pathway and its negative feedback control.

Authors:  Md Kamrul Hasan; Tomoko Yaguchi; Yasumasu Minoda; Takashi Hirano; Kazunari Taira; Renu Wadhwa; Sunil C Kaul
Journal:  Biochem J       Date:  2004-06-15       Impact factor: 3.857

4.  ARF directly binds DP1: interaction with DP1 coincides with the G1 arrest function of ARF.

Authors:  Abhishek Datta; Jayita Sen; Jussara Hagen; Chandrashekhar K Korgaonkar; Michael Caffrey; Dawn E Quelle; Douglas E Hughes; Timothy J Ackerson; Robert H Costa; Pradip Raychaudhuri
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

5.  Intrinsically unstructured domains of Arf and Hdm2 form bimolecular oligomeric structures in vitro and in vivo.

Authors:  Sivashankar G Sivakolundu; Amanda Nourse; Simon Moshiach; Brian Bothner; Chimere Ashley; John Satumba; Jill Lahti; Richard W Kriwacki
Journal:  J Mol Biol       Date:  2008-09-16       Impact factor: 5.469

6.  p53 is positively regulated by miR-542-3p.

Authors:  Yemin Wang; Jen-Wei Huang; Maria Castella; David George Huntsman; Toshiyasu Taniguchi
Journal:  Cancer Res       Date:  2014-04-24       Impact factor: 12.701

7.  ARF impedes NPM/B23 shuttling in an Mdm2-sensitive tumor suppressor pathway.

Authors:  Suzanne N Brady; Yue Yu; Leonard B Maggi; Jason D Weber
Journal:  Mol Cell Biol       Date:  2004-11       Impact factor: 4.272

8.  Role for PP2A in ARF signaling to p53.

Authors:  Madeleine G Moule; Crista H Collins; Frank McCormick; Mike Fried
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-21       Impact factor: 11.205

9.  p19ARF determines the balance between normal cell proliferation rate and apoptosis during mammary gland development.

Authors:  Yijun Yi; Anne Shepard; Frances Kittrell; Biserka Mulac-Jericevic; Daniel Medina; Thenaa K Said
Journal:  Mol Biol Cell       Date:  2004-05       Impact factor: 4.138

10.  Disruption of chromosome 11 in canine fibrosarcomas highlights an unusual variability of CDKN2B in dogs.

Authors:  Jesús Aguirre-Hernández; Bruce S Milne; Chris Queen; Patricia C M O'Brien; Tess Hoather; Sean Haugland; Malcolm A Ferguson-Smith; Jane M Dobson; David R Sargan
Journal:  BMC Vet Res       Date:  2009-07-31       Impact factor: 2.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.